Cody Simmons is the CEO of DermaSensor. I met him when he won the Digital Health Hub Foundation award for diagnostic tools last year. DermaSensor is a device designed to detect early skin cancer using Spectroscopy. Right now only 8% of those with potential skin cancer get the recommended screening. It’s another area where technology can potentially democratize medicine. DermaSensor is aiming for the primary care market. Cody shows how the tool works and explains how the PCP can both improve screening for their patients, and also make money from doing that–otherwise of course they wouldn’t do it! As you can imagine both the technology, the FDA approval process and the roll-out is pretty complicated. Cody explains all–Matthew Holt